This Drug Could be the Most Crucial in Regeneron's Massive Pipeline Post author:Sam Post published:August 22, 2017 Post category:BioPharma August 23, 2017By Mark Terry, BioSpace.com Breaking News… Source: BioSpace You Might Also Like German Biotech InflaRx Snags $100M in IPO November 8, 2017 Biotech Startup Quietly Sets Up Shop in Maryland July 13, 2017 Spark Gets FDA Greenlight for Luxturna, The First Gene Therapy for Eye Disease Approved in the U.S. December 18, 2017
Spark Gets FDA Greenlight for Luxturna, The First Gene Therapy for Eye Disease Approved in the U.S. December 18, 2017
